Atlas Trials

A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC

Clinical trial NCT03741712 · TERMINATED

Trial details

NCT number
NCT03741712
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostate CancerCastration-resistant Prostate Cancer
Start date
2018-11-20
Primary completion
2019-09-30
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.